A Phase 3 Safety, Immunogenicity, Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317
Condition: Chikungunya Virus Interventions: Biological: CHIKV VLP/adjuvant; Biological: Placebo Sponsor: Emergent BioSolutions Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials